Ardent Health Partners, LLC (ARDT) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 8 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for ARDT is $14.14, representing a +50.1% upside from the current price of $9.42. Price targets range from a low of $12.00 to a high of $19.00.